Osteopore (ASX: OSX) deepens its footprint in Australia with MAXONIQ deal

2 min read | May 10, 2022 05:09 PM AEST | By Aditi Sarkar

Google News:

Osteopore (ASX: OSX) deepens its footprint in Australia with MAXONIQ deal — Image source: © Boggy | Megapixl.com

Recent News

ImpediMed (ASX:IPD): Why Has This Healthcare Stock Suddenly Grabbed At...

BHP (ASX:BHP) and ASX 200 ETF Signal Few Investors Are Watching

Why This Reliable ASX Dividend Stock Keeps Rewarding Shareholders

SiteMinder (ASX:SDR): Why Is This Tech Stock Suddenly Back in the Spot...

Make Kalkine Media
My Trusted Source

Highlights

Osteopore strikes a deal with MAXONIQ to promote and market its products in Australia and New Zealand.

Osteomesh® is TGA certified, which will allow MAXONIQ to start engaging with doctors and hospitals immediately

The agreement will provide a stronger foothold to OSX in the Australian market

Osteopore Limited (ASX:OSX), a medical technology company, has taken a significant step towards growing its market in Australia and New Zealand. The company, specialising in innovative regenerative implants, has signed an Exclusive Distribution Agreement with MAXONIQ, an Australian company that focuses on solutions for complex oral and maxillofacial applications.

Under the agreement, MAXONIQ will now promote and sell Osteopore’s products across Australia and New Zealand for orbit reconstruction.

Based in Australia and Singapore, Osteopore commercialises a variety of tailored products particularly engineered to assist bone healing across several therapeutic areas. It is a global leader in producing innovative regenerative implants that enable natural tissue regeneration.

What does the deal bring to the table?

This agreement with MAXONIQ is one of the several initiatives taken by Osteopore to increase the accessibility of its products to surgeons on a global basis.

MAXONIQ has more than six years of design, fabrication, clinical experience, and a well-established network. Further, it has sales and client support required for Osteopore to drive interest amongst surgeons within the sector.

Talking about the deal, Osteopore Executive Chairman Mark Leong said, “This MAXONIQ partnership will help strengthen our reach beyond the Cranial space into the OMF area where our solutions have been successfully adopted in Asia. This also helps us gain a deeper foothold into our home market of Australia.”

Stock information: OSX shares were trading at AU$0.185, with a gain of nearly 3% at 02:35 PM AEST on 10 May 2022.

Also read: MX1, MDR, and OSX: Medical technology stocks from ASX

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.